Lansoprazol Teva

Lansoprazole, the active ingredient in Lansoprazol Teva, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is used to treat acid‑related conditions such as gastro‑esophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Lansoprazol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Customers benefit from consistent product availability and comprehensive regulatory support.

Lansoprazole is a proton pump inhibitor that decreases gastric acid secretion, addressing several acid‑related gastrointestinal disorders.

Gastro‑esophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining higher gastric pH. Erosive esophagitis: promotes healing of inflamed esophageal tissue. Peptic ulcer disease: supports ulcer healing and prevents recurrence. Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic therapy by reducing gastric acidity.

Lansoprazole may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild, transient headache. - Diarrhea: loose stools, usually self‑limiting. - Nausea: feeling of sickness, may improve with food.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis requiring medical attention. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Hypersensitivity reactions: rash, angioedema, or anaphylaxis.

When prescribing lansoprazole, consider the following precautions.

Assess renal function: adjust use in patients with severe renal impairment. Monitor for magnesium levels: prolonged therapy may cause hypomagnesemia. Avoid abrupt discontinuation: may precipitate rebound acid hypersecretion. Use caution in elderly: higher risk of fractures and infections. Store at room temperature: keep in original container, protect from moisture and heat.

Lansoprazole can interact with several medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect when co‑administered. - Atazanavir: decreased absorption of atazanavir, compromising HIV therapy. - Methotrexate (high dose): increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation. - Digoxin: may increase serum levels, monitor for toxicity. - Fluconazole: may raise lansoprazole concentrations, watch for side effects.